Reference
Liu Y, et al. Lung Adenocarcinoma Harboring Triple Rare EGFR Exon 18 Mutations Rapidly Developed Resistance to Multiple Therapies. Chemotherapy (Basel) 67: 248-252, No. 4, 2022. Available from: URL: https://europepmc.org/article/med/35764055
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1962, 43 (2023). https://doi.org/10.1007/s40278-023-41713-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-41713-4